BETHANY DAVIS: Open Payments
NPI 1205459310 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$512 in 25 payments from 12 companies in 2025. Trend: 2023 $894 · 2024 $537 · 2025 $512
Food & beverage: $512
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $108 |
| E.R. Squibb & Sons, L.L.C. | 4 | $89 |
| Janssen Pharmaceuticals, Inc | 3 | $71 |
| ABBVIE INC. | 3 | $48 |
| Supernus Pharmaceuticals, Inc. | 3 | $44 |
| Alkermes, Inc. | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Indivior Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $22 |
Products named: REXULTI, COBENFY, SPRAVATO, VRAYLAR, Qelbree, ARISTADA, AUSTEDO XR, SUBLOCADE.
Industry payments across NV — which companies pay providers there.
